Your browser doesn't support javascript.
loading
Circulating metabolites serve as diagnostic biomarkers for HER2-positive breast cancer and have predictive value for trastuzumab therapy outcomes.
Mao, Changfei; Wang, Min; Li, Li; Tang, Jin-Hai.
Affiliation
  • Mao C; Department of General Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Nanjing, China.
  • Wang M; Department of Pharmacy, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
  • Li L; Department of General Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Nanjing, China.
  • Tang JH; Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
J Clin Lab Anal ; 36(2): e24212, 2022 Feb.
Article in En | MEDLINE | ID: mdl-34994982
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Biomarkers, Tumor / Trastuzumab / Antineoplastic Agents, Immunological Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Clin Lab Anal Journal subject: TECNICAS E PROCEDIMENTOS DE LABORATORIO Year: 2022 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Biomarkers, Tumor / Trastuzumab / Antineoplastic Agents, Immunological Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Clin Lab Anal Journal subject: TECNICAS E PROCEDIMENTOS DE LABORATORIO Year: 2022 Type: Article Affiliation country: China